Meta-Analysis of Outcomes of Endovascular Treatment of Infrapopliteal Occlusive Disease With Drug-Eluting Stents

Santilli JD, Santilli SM. Chronic critical limb ischemia: diagnosis, treatment and prognosis.Am Fam Physician. 1999;59:1899–1908.

10.1136/bmj.326.7389.584

10.1177/1358863X11424312

10.1016/j.jvs.2006.12.037

10.1007/s00270-012-0412-2

10.1053/j.semvascsurg.2012.03.003

10.1016/S1051-0443(07)61332-3

10.1016/j.jvs.2008.01.005

10.1583/09-2691.1

10.1586/erd.11.67

10.1024/0301-1526/a000170

Bosiers M, Deloose K, Callaert J, et al. Drug-eluting stents below the knee.J Cardiovasc Surg (Torino). 2011;52:231–234.

10.1583/11-3665C.1

Rosales OR, Mathewkutty S, Gnaim C. Drug eluting stents for below the knee lesions in patients with critical limb ischemia: long-term follow-up.Catheter Cardiovasc Interv. 2008;72:112–115.

10.1016/j.jvir.2007.07.018

10.1002/ccd.21367

Balzer JO, Zeller T, Rastan A, et al. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents.J Cardiovasc Surg (Torino). 2010;51:183–191.

10.1016/j.jacc.2009.11.072

10.1583/10-3073.1

10.1002/ccd.20893

10.1583/11-3665.1

Lookstein R, Ward T, Kim E, et al. Value of drug-eluting stents after failed percutaneous transluminal angioplasty in the infrapopliteal vessels for the treatment of critical limb ischemia: favorable mid-term patency and limb salvage results.J Cardiovasc Surg (Torino). 2011;52:461–466.

10.1136/bmj.b2700

10.1016/S0741-5214(97)70045-4

10.1016/j.jvs.2011.07.099

10.1093/eurheartj/ehr144

Tepe G, Schmehl J, Heller S, et al. Drug eluting stents versus PTA with GP IIb/IIIa blockade below the knee in patients with current ulcers–The BELOW Study.J Cardiovasc Surg (Torino). 2010;51:203–212.

10.1007/s00330-008-1225-1

Scheinert D, Ulrich M, Scheinert S, et al. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions.EuroIntervention. 2006;2:169–174.

10.1016/j.jvir.2009.05.031

10.1136/bmj.d5928

Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at:http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp; last accessed July 2012.

Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.PLoS Med. 2009;6(7):e1000100.

10.1016/0197-2456(86)90046-2

10.1136/bmj.327.7414.557

10.1136/bmj.315.7109.629

10.4244/EIJV7I9A178

10.1016/j.jvs.2010.02.281

Schwarzwalder U, Zeller T. Below-the-knee revascularization. Advanced techniques.J Cardiovasc Surg (Torino). 2009;50:627–634.

10.1016/j.amjcard.2011.11.021

Serruys PW, Ong AT, Piek JJ, et al. A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial.EuroIntervention. 2005;1:58–65.

10.1007/s00270-012-0370-8

10.1016/j.ejvs.2009.06.016